Summary: Samsung BioLogics plans to spin off its contract manufacturing business from its subsidiaries and new investments, creating a new company called Samsung Episholdings. This move aims to address customer concerns about conflicts of interest and explore new growth opportunities.

Link: https://www.channelnewsasia.com/business/samsung-biologics-spin-separate-contract-drug-making-new-growth-drivers-5145696